Drug Trial Radar · NCT02755545
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments
Last checked: Nov 20, 2026Latest source record: Dec 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
127
Actual
Start
May 1, 2016
Primary completion
Apr 4, 2017
Study completion Apr 4, 2017
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Apr 29, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.
Conditions
- Acne
Interventions
Product ADrug
Product A applied topically to the entire face or other affected area of the skin once daily
Product BDrug
Product B applied topically to affected area of the skin 1 to 3 times daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Total Lesions at Week 12Time frame: Baseline and 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stephens & Associates, Inc. Texas Research Center
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.